Literature DB >> 19730239

Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry.

Yoji Kishi1, Eddie K Abdalla, Yun Shin Chun, Daria Zorzi, David C Madoff, Michael J Wallace, Steven A Curley, Jean-Nicolas Vauthey.   

Abstract

OBJECTIVE(S): This study aimed to determine the effect of preoperative liver volumetry on postoperative outcomes after extended right hepatectomy. Primary end point was to evaluate whether future liver remnant (FLR)/standardized liver volume ratio (sFLR) >20% is sufficient for a safe hepatic resection. Secondary end point was to assess whether preoperative portal vein embolization (PVE) is associated with improved outcome in patients with initial sFLR ≤ 20%. BACKGROUND DATA: An sFLR >20% of the total liver volume has been proposed as sufficient for safe hepatic resection, but this concept has not been validated in a large series. In addition, recent reports suggest preoperative PVE is indicated for sFLR <30%.
METHODS: The impact of sFLR and PVE on short-term outcomes (postoperative complications, liver insufficiency, and 90-day mortality) was analyzed in 301 consecutive patients after extended right hepatectomy. Liver volumetry accounted for partial resection of segment IV. Liver insufficiency was defined as peak postoperative serum bilirubin >7 mg/dL. Predictors of liver insufficiency were identified by multivariate logistic regression.
RESULTS: Postoperative liver insufficiency occurred in 45 patients (15%) and accounted for 61% of deaths. Among 290 patients who underwent liver volumetry, sFLR was <20% in 38 patients, 20.1% to 30% in 144, and ≥ 30% in 108. Rates of postoperative liver insufficiency and death from liver failure were similar between patients with sFLR 20.1% to 30% and sFLR ≥ 30% but higher in patients with sFLR ≤ 20% (P 0.05). Postoperative outcomes were similar between patients with increase in sFLR from ≤ 20% to >20% after PVE and patients with initial sFLR >20%. Multivariate analysis revealed that body mass index >25 kg/m2, intraoperative blood transfusion, and sFLR ≤ 20% (odds ratio = 3.18; 95% CI, 1.34-7.54) independently predicted postoperative liver insufficiency.
CONCLUSIONS: Systematic measurement of FLR volume is important to select patients for PVE and extended right hepatectomy. A sFLR >20% is sufficient for safe hepatic resection and sFLR 20.1% to 30% is not an indication for preoperative PVE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19730239     DOI: 10.1097/SLA.0b013e3181b674df

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  148 in total

1.  Pretreatment assessment of hepatocellular cancer: expert consensus conference.

Authors:  Stephanie R Wilson; Paul Greig; Ahmed O Kaseb
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

2.  Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.

Authors:  Universe Leung; Amber L Simpson; Raphael L C Araujo; Mithat Gönen; Conor McAuliffe; Michael I Miga; E Patricia Parada; Peter J Allen; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; Yuman Fong; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-06-25       Impact factor: 6.113

Review 3.  Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma.

Authors:  Hisashi Nakayama; Tadatoshi Takayama
Journal:  World J Hepatol       Date:  2015-02-27

Review 4.  Nutritional aspects in patient undergoing liver resection.

Authors:  Roberto Ciuni; Antonio Biondi; Giuseppe Grosso; Giuseppe Nunnari; Ettore Panascia; Lisa Randisi; Riccardo Volpes; Antonio Arcadipane; Francesco Basile; Bruno Gridelli; Salvatore Gruttadauria
Journal:  Updates Surg       Date:  2011-11-09

5.  Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases.

Authors:  Yoshikuni Kawaguchi; Scott Kopetz; Timothy E Newhook; Mario De Bellis; Yun Shin Chun; Ching-Wei D Tzeng; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Clin Cancer Res       Date:  2019-06-20       Impact factor: 12.531

6.  Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.

Authors:  Yoshikuni Kawaguchi; Heather A Lillemoe; Elena Panettieri; Yun Shin Chun; Ching-Wei D Tzeng; Thomas A Aloia; Scott Kopetz; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2019-05-02       Impact factor: 6.113

Review 7.  Portal vein embolization in extended liver resection.

Authors:  Nisha Narula; Thomas A Aloia
Journal:  Langenbecks Arch Surg       Date:  2017-05-31       Impact factor: 3.445

8.  Are two-stage hepatectomies associated with more complications than one-stage procedures?

Authors:  Erik Schadde; Ksenija Slankamenac; Stefan Breitenstein; Mickael Lesurtel; Michelle De Oliveira; Beatrice Beck-Schimmer; Philipp Dutkowski; Pierre-Alain Clavien
Journal:  HPB (Oxford)       Date:  2012-11-28       Impact factor: 3.647

9.  Kinetics of liver function tests after a hepatectomy for colorectal liver metastases predict post-operative liver failure as defined by the International Study Group for Liver Surgery.

Authors:  Keith J Roberts; Kishore G S Bharathy; J Peter A Lodge
Journal:  HPB (Oxford)       Date:  2012-10-26       Impact factor: 3.647

10.  Changes in Liver Volume in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy.

Authors:  Julie A Fitzpatrick; Jin Un Kim; Jeremy F L Cobbold; Mark J W McPhail; Mary M E Crossey; Aluel A Bak-Bol; Ashraf Zaky; Simon D Taylor-Robinson
Journal:  J Clin Exp Hepatol       Date:  2015-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.